financetom
Business
financetom
/
Business
/
Arizona Sonoran Files Prospectus for $45 Million Bought-Deal Financing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Arizona Sonoran Files Prospectus for $45 Million Bought-Deal Financing
Jun 13, 2025 8:53 AM

11:34 AM EDT, 06/13/2025 (MT Newswires) -- Arizona Sonoran Copper ( ASCUF ) said Friday it filed a final short form prospectus for its $45 million bought-deal offering.

The company is selling 22.5-million shares priced at $2.00 apiece.

The company also granted the underwriters a 15% overallotment option at the same price.

Arizona Sonoran is advancing the brownfield Cactus project.

The company's shares were last seen down $0.01 to $2.09 on the Toronto Stock Exchange.

Price: 2.09, Change: -0.01, Percent Change: -0.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dr. Reddy's Laboratories Recalls Batch of Levetiracetam in 0.75% Sodium Chloride Injection in US
Dr. Reddy's Laboratories Recalls Batch of Levetiracetam in 0.75% Sodium Chloride Injection in US
Mar 13, 2025
11:12 AM EDT, 03/13/2025 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) said Thursday it is recalling one batch of levetiracetam in 0.75% sodium chloride injection, 1,000 mg/100 mL single-dose infusion bags across the US. The company said it is recalling the product due to the incorrect labeling of the infusion bag which reads as levetiracetam in 0.82% sodium chloride injection...
Kane Biotech Secures Approval to Launch Acne Treatment Trial
Kane Biotech Secures Approval to Launch Acne Treatment Trial
Mar 13, 2025
11:14 AM EDT, 03/13/2025 (MT Newswires) -- Kane Biotech ( KNBIF ) on Thursday said it received approval from the Internal Review Board (IRB) of the University of Miami Health System to launch a clinical study of Kane's prototype DispersinB acne cleanser for the treatment of mild to moderate cases of acne vulgaris. The trial, which is expected to start...
Adobe Investors Need 'Clearer Roadmap' to Dispel 'Apathy' on Shares, Morgan Stanley Says
Adobe Investors Need 'Clearer Roadmap' to Dispel 'Apathy' on Shares, Morgan Stanley Says
Mar 13, 2025
11:10 AM EDT, 03/13/2025 (MT Newswires) -- Adobe (ADBE) investors need a clearer roadmap to dispel apathy surrounding the stock even after the software company's Q1 results topped estimates by analysts, Morgan Stanley said Thursday in a report. Investors look for greater visibility on three key focal points to gain confidence in the forward trajectory of the company, including detailed...
SentinelOne Exceeds Q4 Revenue Expectations, But Guidance Concerns Linger, Oppenheimer Says
SentinelOne Exceeds Q4 Revenue Expectations, But Guidance Concerns Linger, Oppenheimer Says
Mar 13, 2025
11:14 AM EDT, 03/13/2025 (MT Newswires) -- SentinelOne's ( S ) fiscal Q4 revenue exceeded expectations and despite posting strong results near-term investor concerns persist due to lower-than-anticipated guidance for the next fiscal year, Oppenheimer said in a note on Thursday. The company demonstrated strong enterprise adoptions with 1,411 customers generating over $100,000 in annual recurring revenue with 40% of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved